Relation Between Diabetes and Psychiatric Disorders

Depression, anxiety, and schizophrenia are all things that have been found to be linked to the mental health of diabetics. When combined with particular mental health conditions, the management of diabetes might become very challenging. The management of diabetes requires the patient to be actively involved and is contingent on the patient's adherence to prescribed lifestyle modifications, self-monitoring, and medication. Patients who struggle to keep their mental health concerns under control are more likely to have trouble managing their diabetes on their own. People who have diabetes, because it is one of the most cognitively and behaviorally taxing chronic medical conditions, may be especially susceptible to developing mental health disorders. It is more prevalent in those who suffer from mental problems than it is in the general population. Diabetics frequently struggle with a variety of mental health conditions, including but not limited to schizophrenia, anxiety, and depression. Diagnosing and treating mental health disorders is an important component of diabetes treatment that can be accomplished through the collaborative efforts of members of a multidisciplinary team. Patients who fall into this category can benefit from a wide range of services provided by pharmacists who work with them, including individual assessments, joint goal-setting, skill development, ongoing monitoring, and medication management. These services are designed to help patients feel better and function better.


Introduction And Background
Endocrinologists and psychiatrists have long been interested in the intersections between diabetes and mental health treatment. In the 17th century, Thomas Willis argued that diabetes was caused by "lasting melancholy and various depressions" [1]. Within a decade of its discovery, insulin was being used in a psychiatric treatment known as insulin coma therapy. It is only in the last few decades that this connection has received substantial scientific attention. Diabetes and mental health issues have a two-way relationship, with each condition influencing the other in different ways. Several aspects of this link are covered in this article. Tobacco and alcohol, for example, have been demonstrated to have pharmacokinetic effects on oral hypoglycemic medicines [2]. Furthermore, the presence of a coexisting psychiatric disorder, such as depression, may impede diabetes management by lowering medication adherence [1]. Blood glucose testing and insulin injection are only two examples of how investigations and treatments can be complicated by diseases like needle and injection anxiety. Patients with mental health issues are also less likely to seek help [2]. impossible to determine the true prevalence of delirium in diabetes with existing noesiological methodologies due to the use of overlapping terminologies in the body of research that is currently available. However, low blood sugar (hypoglycemia) or diabetic ketoacidosis can lead to delirium, and both of these conditions are common in diabetes patients [12,13]. Several unfavorable consequences have been related to delirium, including lengthened hospitalizations, diminished cognitive and functional abilities, increased morbidity, and even death [14,15]. The clinical picture is characterized by reduced psychomotor activity and an overall sense of calm. Also shared by both forms is a sense of confusion and diminished sensory abilities. Hallucinations, altered sleep-wake patterns, and impaired cognitive function are all clinical features of delirium. Usually, there will be bright spots intermingled with cloudy patches. Prompt detection of delirium can considerably improve the prognosis. While palliative care is important, it is secondary to addressing the underlying cause of the patient's suffering. Low doses of dopaminergic antagonists (typical antipsychotics) may be used to control disruptive behavior [12]. Powerful medications like haloperidol are recommended.

Tobacco
There are combustible (cigarettes, bidi, hookah, and cigars) and noncombustible (chewing tobacco) varieties of tobacco (gutkha, tobacco powder, khaini, snuff). It has been shown that the number of smokers among people with diabetes is similar to that seen in the general population, at least in research conducted by Western researchers [16]. One of the risk factors for developing diabetes is cigarette smoking, although it is a risk factor that may be managed. The increased risk of diabetes appears to be dosage-dependent [17,18]. The use of smokeless tobacco has also been related to an increased risk of acquiring type 2 diabetes, albeit the data is less compelling [19]. When a person smokes cigarettes, they increase their chances of developing microvascular complications like nephropathy, retinopathy, and neuropathy, as well as macrovascular issues like coronary heart disease (CHD), stroke, and peripheral vascular disease (the strongest association in type 2 diabetes) [20]. Gutkha chewing is associated with more severe periodontal disease and tooth pain in diabetics [21]. Hyperglycemia, hyperinsulinemia, and hypertension are postulated to be caused by smoking, as are impaired endothelial function and the pro-diabetogenic activity of tobacco smoke components (e.g., cadmium) [22]. Important questions to ask and provide to patients regarding tobacco use include whether or not they smoke. Most young people with diabetes start smoking soon after their diagnosis, so this is very pertinent for this population [23]. Smoking cessation is associated with weight gain and an increased risk of type 2 diabetes, both of which clinicians should be prepared to address [24]. These effects, however, are either temporary or easily managed through behavioral and lifestyle changes [25]. So, in the years after quitting, smokers should get help managing their weight and be checked for diabetes. Also, it is suggested that the doses of different oral hypoglycemic medicines that are processed by the enzyme system be monitored since smoking makes the cytochrome P450 system make different isoforms. The various drugs used for the treatment of tobacco abuse are listed in Table 1.

Alcoholic beverages
Epidemiological studies and populations seeking treatment have shown that alcoholic beverage consumption is prevalent among people with diabetes, with estimates ranging from 50% to 60% [26,27]. Drinking and developing diabetes is a topic of ongoing debate. Moderate consumption (up to one drink a day for women and up to two drinks a day for men. Examples of one drink include beer: 12 fluid ounces (355 milliliters) and wine: 5 fluid ounces (148 milliliters), which has been shown to be healthy, whereas high consumption is associated with an increased risk of type 2 diabetes [28]. Acute pancreatitis brought on by alcohol consumption might bring on glucose intolerance in alcoholics. Alcohol consumption in diabetes is associated with a number of complications, one of the most common and serious of which is the onset of hypoglycemia. It could be fasting hypoglycemia from alcohol use, drug-induced hypoglycemia that is amplified by alcohol consumption, or reactive hypoglycemia in people who are particularly vulnerable to these conditions. In addition, drinking alcohol can impair one's ability to recognize the first signs of a psychotic episode and take preventative measures [26]. Ketoacidosis from diabetes can progress quickly with alcohol consumption. Diabetic peripheral neuropathy and alcoholic retinopathy can both be caused and exacerbated by the use of these substances. According to a study [29], adherence to diabetes self-care activities is inversely connected to alcohol use. There may be a disulfiram-ethanol interaction if you take chlorpropamide (a sulfonylurea medicine) and drink alcohol together. Alcohol can also induce all of these symptoms simultaneously. In addition to this, drinking alcohol has been related to significant weight gain as well as raised blood sugar levels. In addition, the metabolism of oral hypoglycemic medications can be altered by alcohol consumption. Metformin shouldn't be taken by people who drink a lot of alcohol because it could cause them to get lactic acidosis [29]. Oral hypoglycemics are metabolized in the liver, so people with alcohol-induced hepatopathy may need to reduce their dosage. The various drugs used for the treatment are mentioned in Table 2.

Mood imbalances
Mood disorders include conditions including depression, mania, and hypomania. Multiple epidemiological and clinical research have found a correlation between diabetes and mental health issues [30]. Greater morbidity and death have been associated with this combination. According to a recent study [31,32], patients with diabetes have a 50-100% higher risk of depression than the overall population. Hospital-based research and epidemiological surveys have found that the prevalence of diabetes among bipolar disorder patients is either greater than in the general population or identical [33,34]. Depression due to diabetes is correlated with a higher incidence of complications, mortality, and healthcare costs [35][36][37]. There is a twoway causal connection between diabetes and depression. It is believed that depression contributes to the onset of diabetes [37]. A recent meta-analysis discovered that people who also suffered from depression had a 60% increased risk of developing diabetes [38]. Research has found that all forms of depression, including mild, chronic, and untreated depression, increase the risk of developing diabetes [39]. Mood stabilizers and antipsychotics used to treat bipolar disorders have a more robust database in regard to metabolic derangements. As the term "phenothiazine diabetes" from the 1960s shows, the connection between antipsychotics and diabetes was recognized early on. Due to their metabolic and cardiovascular side effects, newer atypical antipsychotics have attracted a lot of attention. According to Hermanns et al., people who take these medicines are more likely to gain weight and have a harder time handling glucose [40].

Anxiety problems
In comparison to the general population, people with diabetes are substantially more likely to experience anxiety issues [41]. Research has found that anxiety disorders and their associated symptoms are strong independent predictors of developing diabetes. According to Green et al., the risk of developing an anxiety illness is inversely associated with hemoglobin A1c levels [42]. Generalized anxiety disorder (GAD) has been proven to have a prevalence that is almost three times higher than that reported in the general population [43]. On the other hand, the frequencies of these disorders were found to be consistent with those reported in population studies: panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder (PTSD), and agoraphobia [44]. In comparison to studies into the relationship between depression and diabetes, research into the relationship between anxiety disorders and diabetes is sparse. Depression and anxiety in the context of diabetes have been studied mostly together. Both hypoglycemia episode phobia and needle and injection phobia have been linked to diabetes [45]. They are more likely to neglect glucose monitoring and insulin dosing. Additionally, prolonged hyperglycemia could be maintained due to anxiety about hypoglycemia. Clinical signs such as sweating, nervousness, trembling, tachycardia, and confusion are similar between hypoglycemic episodes and anxiety disorders. The fear of hypoglycemic episodes makes this a potential diagnostic concern. People who worry a lot may be more likely to misread or ignore the signs of low blood sugar.

Schizophrenia and other psychotic conditions
Diabetes is strongly associated with a number of medical conditions, one of which is psychosis. Compared to other diseases, people who have been diagnosed with schizophrenia are at higher risk to get type 2 diabetes [40]. People who are related to schizophrenia patients, even first cousins, are at a considerably higher risk of developing type 2 diabetes. Because of a favorable family history, people with schizophrenia may have a threefold increased risk of developing diabetes [41]. According to the available data, patients with both diabetes and schizophrenia have an increased risk of death [42]. More people with schizophrenia are diagnosed with type 2 diabetes, which is linked to a higher mortality rate for those who have schizophrenia. Low glucose tolerance and insulin resistance have both been associated with schizophrenia [37]. Schizophrenia patients may have impaired glucose tolerance at a rate as high as 30%, depending on their age. Schizophrenia patients have an increased chance of developing diabetes, which is likely due to both hereditary and environmental causes. Not getting enough exercise, eating poorly, not getting proper medical care, and using antipsychotic drugs are also contributors. Initial studies suggest that schizophrenia may be a separate risk factor for developing diabetes [37,38,44]. Furthermore, there is a 50% nonadherence rate among those with schizophrenia who are receiving treatment. Because of this, their managers will be forced to make some tough decisions.

Conclusions
Diabetes is a growing public health concern. Many diabetics struggle to improve their diabetes control, often due to mental illnesses or psychological and social issues. Diabetes has serious consequences for the individual and, if not addressed, can lead to complications such as blindness, kidney failure, and even amputations. There are also implications for healthcare services as a result of increased admissions and emergency department presentations with diabetes-related complications. The long-term costs associated with complications such as renal failure and amputation are significant. Addressing the psychiatric and psychological barriers to good glucose control can help reduce the individual and societal burdens of diabetes and its complications.

Conflicts of interest:
In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.